{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:46:52Z","timestamp":1794703612156,"version":"4.9.1"},"reference-count":456,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1,1]]},"DOI":"10.1093\/eurheartj\/ehv317","type":"journal-article","created":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T19:59:19Z","timestamp":1440878359000},"page":"67-119","source":"Crossref","is-referenced-by-count":5198,"title":["2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension"],"prefix":"10.1093","volume":"37","author":[{"given":"Nazzareno","family":"Gali\u00e8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Vachiery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Torbicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rald","family":"Simonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Vonk Noordegraaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Beghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardeschir","family":"Ghofrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Gomez Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Klepetko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizio","family":"Lancellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Matucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"McDonagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc A.","family":"Pierard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro T.","family":"Trindade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Zompatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Hoeper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ESC Scientific Document Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Aboyans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vaz Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Achenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Agewall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Asteggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi Paolo","family":"Badano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Albert","family":"Barber\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Bouvaist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scipione","family":"Carerj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u00e7a","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7etin","family":"Erol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkmar","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Funck-Brentano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Gorenflo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Granton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Iung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G","family":"Kiely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbro","family":"Kjellstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Landmesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lekakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Lionis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos E","family":"Orfanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung H","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo F","family":"Piepoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Revel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rigau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Rosenkranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"V\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Zamorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Zamorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Aboyans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Achenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Agewall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Badimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Bar\u00f3n-Esquivias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen J","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scipione","family":"Carerj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7etin","family":"Erol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Fitzsimons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Gaemperli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Kolh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizio","family":"Lancellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory YH","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Nihoyannopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo F","family":"Piepoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Roffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Torbicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vaz Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sokol","family":"Myftiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Bonderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahimov","family":"Firdovsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Lazareva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"De Pauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0160ekib","family":"Sokolovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasil","family":"Velchev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Cike\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef Antoniou","family":"Moutiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Jansa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Erik","family":"Nielsen-Kudsk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ly","family":"Anton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pertti","family":"J\u00e4\u00e4skel\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archil","family":"Chukhrukidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Giannakoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krist\u00f3f","family":"Karl\u00f3cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hj\u00f6rtur","family":"Oddsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Gaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Menachemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Emdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talant","family":"Sooronbaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talant Ainars","family":"Rudzitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Gumbiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Lebrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Botnaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latifa","family":"Oukerraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne K","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Kurzyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jo\u00e3o Ribeiro","family":"Leite Baptista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioan Mircea","family":"Coman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Moiseeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branislav S","family":"Stefanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iveta","family":"\u0160imkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Wikstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Schwerzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeta","family":"Srbinovska-Kostovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie P J","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"Mahdhaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihangir","family":"Kaymaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry","family":"Coghlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriy","family":"Sirenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,8,29]]},"reference":[{"issue":"(Suppl)","key":"2026080920424209200_EHV317C1","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C2","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1183\/09031936.00145608","article-title":"Pulmonary arterial pressure during rest and exercise in healthy subjects A systematic review","volume":"34","author":"Kovacs","year":"2009","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1183\/09031936.00021915","article-title":"Criteria for diagnosis of exercise pulmonary hypertension","volume":"46","author":"Herve","year":"2015","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C4","doi-asserted-by":"crossref","first-page":"D100","DOI":"10.1016\/j.jacc.2013.10.033","article-title":"Pulmonary hypertension due to left heart disease","volume":"62","author":"Vachiery","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2004.02.037","article-title":"Clinical classification of pulmonary hypertension","author":"Simonneau","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C6","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C7","doi-asserted-by":"crossref","first-page":"F223","DOI":"10.1136\/adc.2009.180091","article-title":"The management of neonatal pulmonary hypertension","volume":"97","author":"Dhillon","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2026080920424209200_EHV317C8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.clp.2011.12.006","article-title":"Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents","volume":"39","author":"Porta","year":"2012","journal-title":"Clin Perinatol"},{"key":"2026080920424209200_EHV317C9","doi-asserted-by":"crossref","first-page":"D117","DOI":"10.1016\/j.jacc.2013.10.028","article-title":"Pediatric pulmonary hypertension","volume":"62","author":"Ivy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1183\/09031936.00092306","article-title":"An epidemiological study of pulmonary arterial hypertension","volume":"30","author":"Peacock","year":"2007","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2013.10.023","article-title":"Pulmonary arterial hypertension: epidemiology and registries","author":"McGoon","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C14","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1161\/CIRCULATIONAHA.111.079921","article-title":"Pulmonary arterial hypertension in patients treated by dasatinib","volume":"125","author":"Montani","year":"2012","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C15","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1183\/09031936.00188611","article-title":"Pulmonary hypertension associated with benfluorex exposure","volume":"40","author":"Savale","year":"2012","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C16","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1183\/09031936.00057914","article-title":"Pulmonary arterial hypertension in patients treated with interferon","volume":"44","author":"Savale","year":"2014","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2009.04.011","article-title":"Diagnosis and assessment of pulmonary arterial hypertension","author":"Badesch","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ccm.2006.12.001","article-title":"Pulmonary hypertension associated with left-sided heart disease","volume":"28","author":"Oudiz","year":"2007","journal-title":"Clin Chest Med"},{"key":"2026080920424209200_EHV317C19","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012)","volume":"33","author":"Vahanian","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080920424209200_EHV317C20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2013.10.036","article-title":"Pulmonary hypertension in chronic lung diseases","author":"Seeger","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C21","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1183\/09031936.00079512","article-title":"Pulmonary hypertension in COPD: results from the ASPIRE registry","volume":"41","author":"Hurdman","year":"2013","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1183\/09031936.05.00021005","article-title":"Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity","volume":"26","author":"Cottin","year":"2005","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C23","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1183\/09031936.00101211","article-title":"Survival in pulmonary hypertension in Spain: insights from the Spanish registry","volume":"40","author":"Escribano-Subias","year":"2012","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C24","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa032274","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism","volume":"350","author":"Pengo","year":"2004","journal-title":"N Engl J Med"},{"key":"2026080920424209200_EHV317C25","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.110.015008","article-title":"Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry","volume":"124","author":"Pepke-Zaba","year":"2011","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2013.10.035","article-title":"Genetics and genomics of pulmonary arterial hypertension","author":"Soubrier","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa1211097","article-title":"A novel channelopathy in pulmonary arterial hypertension","volume":"369","author":"Ma","year":"2013","journal-title":"N Engl J Med"},{"key":"2026080920424209200_EHV317C28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ng.2844","article-title":"EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension","volume":"46","author":"Eyries","year":"2014","journal-title":"Nat Genet"},{"key":"2026080920424209200_EHV317C29","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1161\/01.CIR.0000091409.53101.E8","article-title":"Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease","volume":"108","author":"Eddahibi","year":"2003","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C30","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1183\/09031936.00089610","article-title":"A noninvasive algorithm to exclude pre-capillary pulmonary hypertension","volume":"37","author":"Bonderman","year":"2011","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C31","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijcard.2012.03.071","article-title":"QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension","volume":"167","author":"Rich","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026080920424209200_EHV317C32","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1378\/chest.10-3331","article-title":"Prolonged QRS duration: a new predictor of adverse outcome in idiopathic pulmonary arterial hypertension","volume":"141","author":"Sun","year":"2012","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C33","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.ijcard.2012.06.024","article-title":"Atrial flutter and fibrillation in patients with pulmonary hypertension","volume":"167","author":"Olsson","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026080920424209200_EHV317C34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension: a national prospective study","volume":"107","author":"Rich","year":"1987","journal-title":"Ann Intern Med"},{"key":"2026080920424209200_EHV317C35","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1148\/rg.324125021","article-title":"Forgotten gold in diagnosing pulmonary hypertension: the plain chest radiograph","volume":"32","author":"Milne","year":"2012","journal-title":"Radiographics"},{"key":"2026080920424209200_EHV317C36","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1183\/09031936.00184412","article-title":"Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses","volume":"42","author":"Trip","year":"2013","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C37","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0735-1097(02)02964-9","article-title":"Pulmonary function in primary pulmonary hypertension","volume":"41","author":"Sun","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C38","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1183\/09031936.00134506","article-title":"Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension","volume":"29","author":"Hoeper","year":"2007","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C39","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino","year":"2005","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C40","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000110207","article-title":"Cardiopulmonary exercise test characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension","volume":"76","author":"Holverda","year":"2008","journal-title":"Respiration"},{"key":"2026080920424209200_EHV317C41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1378\/chest.11-3124","article-title":"High occurrence of hypoxemic sleep respiratory disorders in precapillary pulmonary hypertension and mechanisms","volume":"143","author":"Jilwan","year":"2013","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C42","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1378\/chest.120.3.894","article-title":"Nocturnal hypoxemia is common in primary pulmonary hypertension","volume":"120","author":"Rafanan","year":"2001","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C43","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","article-title":"Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography","volume":"23","author":"Rudski","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080920424209200_EHV317C44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080920424209200_EHV317C45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/hrt.56.1.33","article-title":"Echocardiographic measurement of the normal adult right ventricle","volume":"56","author":"Foale","year":"1986","journal-title":"Br Heart J"},{"key":"2026080920424209200_EHV317C46","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","article-title":"Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study","volume":"52","author":"Hachulla","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2026080920424209200_EHV317C47","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2967\/jnumed.106.039438","article-title":"Ventilation-perfusion scintigraphy Is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension","volume":"48","author":"Tunariu","year":"2007","journal-title":"J Nucl Med"},{"key":"2026080920424209200_EHV317C48","first-page":"177","article-title":"[A comparison of ventilation\/perfusion single photon emission CT and CT pulmonary angiography for diagnosis of pulmonary embolism]","volume":"36","author":"Meng","year":"2013","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"2026080920424209200_EHV317C49","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/thoraxjnl-2012-203020","article-title":"3D contrast-enhanced lung perfusion MRI is an effective screening tool for chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry","volume":"68","author":"Rajaram","year":"2013","journal-title":"Thorax"},{"key":"2026080920424209200_EHV317C50","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/thoraxjnl-2014-206088","article-title":"CT features of pulmonary arterial hypertension and its major subtypes: a systematic CT evaluation of 292 patients from the ASPIRE Registry","volume":"70","author":"Rajaram","year":"2015","journal-title":"Thorax"},{"key":"2026080920424209200_EHV317C51","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1097\/MD.0000000000000256","article-title":"CT-base pulmonary artery measurement in the detection of pulmonary hypertension: a meta-analysis and systematic review","volume":"93","author":"Shen","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"2026080920424209200_EHV317C52","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1378\/chest.113.5.1250","article-title":"Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease","volume":"113","author":"Tan","year":"1998","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2214\/ajr.183.1.1830065","article-title":"Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease","volume":"183","author":"Resten","year":"2004","journal-title":"Am J Roentgenol"},{"key":"2026080920424209200_EHV317C54","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1183\/09031936.04.00079704","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"23","author":"Dartevelle","year":"2004","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejrad.2008.03.016","article-title":"Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angiography","volume":"71","author":"Reichelt","year":"2008","journal-title":"Eur J Radiol"},{"key":"2026080920424209200_EHV317C56","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMra010902","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"345","author":"Fedullo","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080920424209200_EHV317C57","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1183\/09031936.00012914","article-title":"Right ventricular reverse remodelling after balloon pulmonary angioplasty","volume":"43","author":"Fukui","year":"2014","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C58","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1053\/j.sult.2012.05.001","article-title":"Imaging findings in pulmonary vasculitis","volume":"33","author":"Castaner","year":"2012","journal-title":"Semin Ultrasound CT MR"},{"key":"2026080920424209200_EHV317C59","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.jvir.2008.07.011","article-title":"Digital subtraction pulmonary arteriography versus multidetector CT in the detection of pulmonary arteriovenous malformations","volume":"19","author":"Nawaz","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"2026080920424209200_EHV317C60","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1183\/09059180.00006313","article-title":"Cardiac magnetic resonance imaging in pulmonary arterial hypertension","volume":"22","author":"Peacock","year":"2013","journal-title":"Eur Respir Rev"},{"key":"2026080920424209200_EHV317C61","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1532-429X-14-40","article-title":"Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry","volume":"14","author":"Swift","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026080920424209200_EHV317C62","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jcmg.2013.01.013","article-title":"Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry","volume":"6","author":"Swift","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080920424209200_EHV317C63","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1007\/s00330-003-1878-8","article-title":"Value of contrast-enhanced MR angiography and helical CT angiography in chronic thromboembolic pulmonary hypertension","volume":"13","author":"Ley","year":"2003","journal-title":"Eur Radiol"},{"key":"2026080920424209200_EHV317C64","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/eurheartj\/ehl477","article-title":"Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension","volume":"28","author":"van Wolferen","year":"2007","journal-title":"Eur Heart J"},{"key":"2026080920424209200_EHV317C65","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCIMAGING.113.000629","article-title":"Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension\u2013targeted therapy: the EURO-MR Study","volume":"7","author":"Peacock","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080920424209200_EHV317C66","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jacc.2011.06.068","article-title":"Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy","volume":"58","author":"van de Veerdonk","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C67","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(98)06373-9","article-title":"Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent","volume":"353","author":"Albrecht","year":"1999","journal-title":"Lancet"},{"key":"2026080920424209200_EHV317C68","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4414\/smw.2003.10016","article-title":"Hepatopulmonary syndrome and portopulmonary hypertension","volume":"133","author":"Naeije","year":"2003","journal-title":"Swiss Med Wkly"},{"key":"2026080920424209200_EHV317C69","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.jacc.2006.07.061","article-title":"Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers","volume":"48","author":"Hoeper","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C70","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1164\/rccm.201402-0269PP","article-title":"Reading pulmonary vascular pressure tracings","volume":"190","author":"Kovacs","year":"2014","journal-title":"How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C71","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1164\/ajrccm.160.2.9811062","article-title":"Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension","volume":"160","author":"Hoeper","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C72","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1378\/chest.11-1387","article-title":"Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mm Hg: insights from the REVEAL Registry","volume":"143","author":"Frost","year":"2013","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C73","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"key":"2026080920424209200_EHV317C74","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCHEARTFAILURE.109.867044","article-title":"Characterization of static and dynamic left ventricular diastolic function in patients with heart failure with a preserved ejection fraction","volume":"3","author":"Prasad","year":"2010","journal-title":"Circ Heart Fail"},{"key":"2026080920424209200_EHV317C75","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/CIRCULATIONAHA.112.111302","article-title":"Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure","volume":"127","author":"Fujimoto","year":"2013","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C76","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1183\/09031936.00091212","article-title":"High prevalence of occult left heart disease in scleroderma-pulmonary hypertension","volume":"42","author":"Fox","year":"2013","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C77","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/CIRCHEARTFAILURE.113.000468","article-title":"High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension","volume":"7","author":"Robbins","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2026080920424209200_EHV317C78","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","article-title":"Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction","volume":"3","author":"Borlaug","year":"2010","journal-title":"Circ Heart Fail"},{"key":"2026080920424209200_EHV317C79","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1752-699X.2012.00310.x","article-title":"Exercise during cardiac catheterization distinguishes between pulmonary and left ventricular causes of dyspnea in systemic sclerosis patients","volume":"7","author":"Hager","year":"2013","journal-title":"Clin Respir J"},{"key":"2026080920424209200_EHV317C80","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1378\/chest.08-2784","article-title":"Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure","volume":"136","author":"Halpern","year":"2009","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C81","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1183\/09031936.00074312","article-title":"The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease","volume":"41","author":"Naeije","year":"2013","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C82","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1183\/09031936.00009008","article-title":"Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension","volume":"32","author":"Provencher","year":"2008","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C83","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.healun.2013.11.008","article-title":"Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension","volume":"33","author":"Tedford","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"2026080920424209200_EHV317C84","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension [see comments]","volume":"327","author":"Rich","year":"1992","journal-title":"N Engl J Med"},{"key":"2026080920424209200_EHV317C85","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C86","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2004.02.032","article-title":"Diagnosis and differential assessment of pulmonary arterial hypertension","author":"Barst","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C87","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/01.CIR.84.3.1145","article-title":"Adenosine as a vasodilator in primary pulmonary hypertension [see comments]","volume":"84","author":"Morgan","year":"1991","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C88","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1378\/chest.107.1.54","article-title":"Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension","volume":"107","author":"Nootens","year":"1995","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C89","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0735-1097(99)00494-5","article-title":"A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension","volume":"35","author":"Hoeper","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C90","first-page":"356","article-title":"Assessment of the vasodilator response in primary pulmonary hypertension","volume":"24","author":"Opitz","year":"2003","journal-title":"Comparing prostacyclin and iloprost administered by either infusion or inhalation. Eur Heart J"},{"key":"2026080920424209200_EHV317C91","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1016\/j.jacc.2013.10.024","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"62","author":"Kim","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C92","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/09031936.00090608","article-title":"Pulmonary veno-occlusive disease","volume":"33","author":"Montani","year":"2009","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C93","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MNM.0b013e32835085d9","article-title":"Diagnosis of chronic thromboembolic pulmonary hypertension: comparison of ventilation\/perfusion scanning and multidetector computed tomography pulmonary angiography with pulmonary angiography","volume":"33","author":"He","year":"2012","journal-title":"Nucl Med Commun"},{"key":"2026080920424209200_EHV317C94","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1183\/09031936.00038709","article-title":"Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome","volume":"35","author":"Cottin","year":"2010","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C95","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0025-6196(11)60747-7","article-title":"Wide variation in clinicians' assessment of New York Heart Association\/World Health Organization functional class in patients with pulmonary arterial hypertension","volume":"84","author":"Taichman","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"2026080920424209200_EHV317C96","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","article-title":"Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival","volume":"40","author":"Sitbon","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C97","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1183\/09031936.00092311","article-title":"The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension","volume":"39","author":"Nickel","year":"2012","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C98","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1378\/chest.12-2417","article-title":"Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry","volume":"144","author":"Barst","year":"2013","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C99","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C100","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1183\/09031936.05.00054804","article-title":"Survival with first-line bosentan in patients with primary pulmonary hypertension","volume":"25","author":"McLaughlin","year":"2005","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C101","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1378\/chest.10-2015","article-title":"Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertension","volume":"139","author":"Sachdev","year":"2011","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C102","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0735-1097(02)01744-8","article-title":"Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension","volume":"39","author":"Raymond","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C103","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1067\/mje.2002.123962","article-title":"Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension","volume":"15","author":"Bustamante-Labarta","year":"2002","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080920424209200_EHV317C104","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1164\/rccm.200604-547OC","article-title":"Tricuspid annular displacement predicts survival in pulmonary hypertension","volume":"174","author":"Forfia","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C105","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1183\/09031936.00072709","article-title":"Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation","volume":"35","author":"Thenappan","year":"2010","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C106","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/01.CIR.0000022687.18568.2A","article-title":"Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing","volume":"106","author":"Wensel","year":"2002","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C107","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/01.CIR.0000029100.82385.58","article-title":"Survival in primary pulmonary hypertension: the impact of epoprostenol therapy","volume":"106","author":"McLaughlin","year":"2002","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C108","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/CIRCIMAGING.113.000640","article-title":"Outcome prediction by quantitative right ventricular function assessment in 575 subjects evaluated for pulmonary hypertension","volume":"6","author":"Fine","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080920424209200_EHV317C109","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.echo.2010.06.029","article-title":"Accuracy of right ventricular volumes and function determined by three-dimensional echocardiography in comparison with magnetic resonance imaging: a meta-analysis study","volume":"23","author":"Shimada","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080920424209200_EHV317C110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jacc.2014.01.084","article-title":"Three-dimensional speckle tracking of the right ventricle: toward optimal quantification of right ventricular dysfunction in pulmonary hypertension","volume":"64","author":"Smith","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C111","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1161\/CIRCULATIONAHA.113.001573","article-title":"Assessment and prognostic relevance of right ventricular contractile reserve in patients with severe pulmonary hypertension","volume":"128","author":"Grunig","year":"2013","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C112","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00330-011-2306-0","article-title":"Black blood MRI has diagnostic and prognostic value in the assessment of patients with pulmonary hypertension","volume":"22","author":"Swift","year":"2012","journal-title":"Eur Radiol"},{"key":"2026080920424209200_EHV317C113","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/CIRCIMAGING.113.000338","article-title":"Prognostic value of cardiovascular magnetic resonance imaging measurements corrected for age and sex in idiopathic pulmonary arterial hypertension","volume":"7","author":"Swift","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080920424209200_EHV317C114","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/thx.2005.040618","article-title":"Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol","volume":"60","author":"Sitbon","year":"2005","journal-title":"Thorax"},{"key":"2026080920424209200_EHV317C115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1183\/09031936.00102212","article-title":"Noninvasive cardiac output measurements in patients with pulmonary hypertension","volume":"42","author":"Rich","year":"2013","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C116","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jacc.2012.01.083","article-title":"Do changes of 6-minute walk distance predict clinical events in patients with pulmonary arterial hypertension?: a meta-analysis of 22 randomized trials","volume":"60","author":"Savarese","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C117","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/CIRCULATIONAHA.112.105890","article-title":"Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials","volume":"126","author":"Gabler","year":"2012","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C118","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1378\/chest.12-0270","article-title":"Baseline and follow-up 6-min walk distance and brain natriuretic peptide predict 2-year mortality in pulmonary arterial hypertension","volume":"143","author":"Fritz","year":"2013","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C119","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1183\/09031936.01.17406470","article-title":"Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension","volume":"17","author":"Paciocco","year":"2001","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1183\/09031936.06.00042705","article-title":"Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension","volume":"27","author":"Provencher","year":"2006","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C121","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/hc2901.093198","article-title":"Exercise pathophysiology in patients with primary pulmonary hypertension","volume":"104","author":"Sun","year":"2001","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C122","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ijcard.2012.03.135","article-title":"Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension","volume":"167","author":"Wensel","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026080920424209200_EHV317C123","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/eurjhf\/hft044","article-title":"Impact of right ventricular reserve on exercise capacity and survival in patients with pulmonary hypertension","volume":"15","author":"Blumberg","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026080920424209200_EHV317C124","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.104.529800","article-title":"Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication","volume":"112","author":"Diller","year":"2005","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.healun.2009.09.003","article-title":"Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: an evidence-based review","volume":"29","author":"Arena","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"2026080920424209200_EHV317C126","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1096\/fj.04-3223fje","article-title":"Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension","volume":"19","author":"Pullamsetti","year":"2005","journal-title":"FASEB J"},{"key":"2026080920424209200_EHV317C127","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1161\/01.ATV.0000168414.06853.f0","article-title":"Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension","volume":"25","author":"Kielstein","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026080920424209200_EHV317C128","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/01.CIR.0000105764.22626.B1","article-title":"Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans","volume":"109","author":"Kielstein","year":"2004","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C129","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1378\/chest.128.4.2355","article-title":"von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension","volume":"128","author":"Kawut","year":"2005","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C130","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1093\/eurheartj\/ehq226","article-title":"Circulating angiopoietins in idiopathic pulmonary arterial hypertension","volume":"31","author":"Kumpers","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080920424209200_EHV317C131","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1378\/chest.120.5.1562","article-title":"Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension","volume":"120","author":"Rubens","year":"2001","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C132","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jacc.2008.12.038","article-title":"C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension","volume":"53","author":"Quarck","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C133","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1164\/rccm.2106007","article-title":"CX(3)C chemokine fractalkine in pulmonary arterial hypertension","volume":"165","author":"Balabanian","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C134","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1164\/ajrccm.165.4.2012112","article-title":"Chemokine RANTES in severe pulmonary arterial hypertension","volume":"165","author":"Dorfmuller","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C135","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1164\/ajrccm.151.5.7735624","article-title":"Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension","volume":"151","author":"Humbert","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C136","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.CIR.102.8.865","article-title":"Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension","volume":"102","author":"Nagaya","year":"2000","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C137","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1378\/chest.06-1758","article-title":"N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension","volume":"131","author":"Leuchte","year":"2007","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C138","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1378\/chest.129.5.1313","article-title":"Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension","volume":"129","author":"Fijalkowska","year":"2006","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C139","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.CIR.0000084544.54513.E2","article-title":"Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension","volume":"108","author":"Torbicki","year":"2003","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C140","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1164\/rccm.200802-235OC","article-title":"Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension","volume":"178","author":"Nickel","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C141","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/ajrccm.160.2.9812078","article-title":"Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension","volume":"160","author":"Nagaya","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C142","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1378\/chest.10-1146","article-title":"Osteopontin in patients with idiopathic pulmonary hypertension","volume":"139","author":"Lorenzen","year":"2011","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C143","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1183\/09031936.00160307","article-title":"Biomarkers in pulmonary hypertension","volume":"32","author":"Warwick","year":"2008","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C144","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1183\/09031936.05.00075305","article-title":"Goal-oriented treatment and combination therapy for pulmonary arterial hypertension","volume":"26","author":"Hoeper","year":"2005","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2013.10.034","article-title":"Treatment goals of pulmonary hypertension","author":"McLaughlin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C146","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/eurheartj\/ehp022","article-title":"A meta-analysis of randomized controlled trials in pulmonary arterial hypertension","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080920424209200_EHV317C147","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000334431","article-title":"Combination therapy in pulmonary arterial hypertension: a meta-analysis","volume":"120","author":"Bai","year":"2011","journal-title":"Cardiology"},{"key":"2026080920424209200_EHV317C148","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2013.10.030","article-title":"The Fifth World Symposium on Pulmonary Arterial Hypertension","author":"Gali\u00e8","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C149","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2013.06.032","article-title":"Updated treatment algorithm of pulmonary hypertension","author":"Gali\u00e8","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C150","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/01.psy.0000145593.37594.39","article-title":"Anxiety and depression in patients with pulmonary hypertension","volume":"66","author":"L\u00f6we","year":"2004","journal-title":"Psychosom Med"},{"key":"2026080920424209200_EHV317C151","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines on diagnosis and treatment of pulmonary hypertension: the Task Force on Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology and of the European Respiratory Society","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080920424209200_EHV317C152","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/CIRCULATIONAHA.106.618397","article-title":"Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension","volume":"114","author":"Mereles","year":"2006","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C153","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1183\/09031936.00027909","article-title":"Effects of exercise training in patients with idiopathic pulmonary arterial hypertension","volume":"34","author":"de Man","year":"2009","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C154","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000322475","article-title":"Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension","volume":"81","author":"Grunig","year":"2011","journal-title":"Respiration"},{"key":"2026080920424209200_EHV317C155","doi-asserted-by":"crossref","first-page":"R148","DOI":"10.1186\/ar3883","article-title":"Exercise training in pulmonary arterial hypertension associated with connective tissue diseases","volume":"14","author":"Grunig","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2026080920424209200_EHV317C156","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1183\/09031936.00123711","article-title":"Safety and efficacy of exercise training in various forms of pulmonary hypertension","volume":"40","author":"Grunig","year":"2012","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C157","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijcard.2012.09.036","article-title":"Efficacy of exercise training in pulmonary arterial hypertension associated with congenital heart disease","volume":"168","author":"Becker-Grunig","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026080920424209200_EHV317C158","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.rmed.2013.02.006","article-title":"Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension","volume":"107","author":"Weinstein","year":"2013","journal-title":"Respir Med"},{"key":"2026080920424209200_EHV317C159","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1378\/chest.12-0993","article-title":"Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension","volume":"143","author":"Chan","year":"2013","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C160","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1183\/09031936.00141211","article-title":"Pregnancy outcomes in pulmonary arterial hypertension in the modern management era","volume":"40","author":"Ja\u00efs","year":"2012","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C161","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1378\/chest.12-0528","article-title":"Management of pulmonary arterial hypertension during pregnancy: a retrospective, multicenter experience","volume":"143","author":"Duarte","year":"2013","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C162","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1783\/147118906776276486","article-title":"Pregnancy and contraception in heart disease and pulmonary arterial hypertension","volume":"32","author":"Thorne","year":"2006","journal-title":"J Fam Plann Reprod Health Care"},{"key":"2026080920424209200_EHV317C163","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/01.AOG.0000164074.64137.f1","article-title":"Pregnancy outcome in patients with pulmonary arterial hypertension receiving prostacyclin therapy","volume":"106","author":"Bendayan","year":"2005","journal-title":"Obstet Gynecol"},{"key":"2026080920424209200_EHV317C164","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00000542-200506000-00012","article-title":"Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases","volume":"102","author":"Bonnin","year":"2005","journal-title":"Anesthesiology"},{"key":"2026080920424209200_EHV317C165","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1183\/09031936.00089212","article-title":"Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey","volume":"41","author":"Meyer","year":"2013","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C166","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1399-6576.2001.450220.x","article-title":"Cesarean section under epidural ropivacaine 0.75% in a parturient with severe pulmonary hypertension","volume":"45","author":"Olofsson","year":"2001","journal-title":"Acta Anaesthesiol Scand"},{"key":"2026080920424209200_EHV317C167","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0952-8180(96)00084-0","article-title":"Anesthetic management and outcome following noncardiac surgery in nonparturients with Eisenmenger's physiology","volume":"8","author":"Raines","year":"1996","journal-title":"J Clin Anesth"},{"key":"2026080920424209200_EHV317C168","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1183\/09059180.00005713","article-title":"Understanding the impact of pulmonary arterial hypertension on patients\u2019 and carers\u2019 lives","volume":"22","author":"Guillevin","year":"2013","journal-title":"Eur Respir Rev"},{"key":"2026080920424209200_EHV317C169","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1164\/arrd.1985.131.4.493","article-title":"Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease","volume":"131","author":"Weitzenblum","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"2026080920424209200_EHV317C170","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1183\/09031936.00185011","article-title":"Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation","volume":"39","author":"Frydman","year":"2012","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C171","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.70.4.580","article-title":"Primary pulmonary hypertension: natural history and the importance of thrombosis","volume":"70","author":"Fuster","year":"1984","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C172","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0272-5231(05)70283-5","article-title":"Pathobiology of pulmonary hypertension: the role of platelets and thrombosis","volume":"22","author":"Herve","year":"2001","journal-title":"Clin Chest Med"},{"key":"2026080920424209200_EHV317C173","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1183\/09031936.98.12061446","article-title":"Plasma coagulation profiles in patients with severe primary pulmonary hypertension","volume":"12","author":"Hoeper","year":"1998","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C174","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1164\/ajrccm.150.4.7921465","article-title":"Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertension","volume":"150","author":"Huber","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCULATIONAHA.113.004526","article-title":"Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)","volume":"129","author":"Olsson","year":"2014","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C176","first-page":"10","article-title":"Anticoagulant therapy does not influence long-term outcomes in patients with pulmonary arterial hypertension (PAH): insights from the randomised controlled SERAPHIN trial of macitentan","volume":"35","author":"Gali\u00e8","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080920424209200_EHV317C177","first-page":"A2464","article-title":"Effect of warfarin treatment on survival of patients with pulmonary arterial hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)","volume":"189","author":"Preston","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C178","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9343(01)00915-9","article-title":"Optimal diuretic therapy for heart failure","volume":"111","author":"Cohn","year":"2001","journal-title":"Am J Med"},{"key":"2026080920424209200_EHV317C179","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1164\/ajrccm.164.9.2106076","article-title":"Nocturnal oxygen therapy in patients with the Eisenmenger syndrome","volume":"164","author":"Sandoval","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C180","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1378\/chest.114.3.787","article-title":"The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension","volume":"114","author":"Rich","year":"1998","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C181","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1183\/09031936.00100510","article-title":"Iron deficiency is common in idiopathic pulmonary arterial hypertension","volume":"37","author":"Ruiter","year":"2011","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C182","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/rheumatology\/ket331","article-title":"Iron deficiency in systemic sclerosis patients with and without pulmonary hypertension","volume":"53","author":"Ruiter","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"2026080920424209200_EHV317C183","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jacc.2006.03.040","article-title":"Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease","volume":"48","author":"Broberg","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C184","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2011.02.057","article-title":"Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension clinical prevalence, outcomes, and mechanistic insights","volume":"58","author":"Rhodes","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C185","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1093\/eurheartj\/ehr130","article-title":"Iron deficiency is associated with adverse outcome in Eisenmenger patients","volume":"32","author":"Van De Bruaene","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080920424209200_EHV317C186","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijcard.2014.04.233","article-title":"Ferric carboxymaltose improves exercise capacity and quality of life in patients with pulmonary arterial hypertension and iron deficiency: a pilot study","volume":"175","author":"Viethen","year":"2014","journal-title":"Int J Cardiol"},{"key":"2026080920424209200_EHV317C187","doi-asserted-by":"crossref","first-page":"55A","DOI":"10.1016\/S0002-9149(99)80384-1","article-title":"Role of pharmacologic tests in the treatment of primary pulmonary hypertension","volume":"75","author":"Gali\u00e9","year":"1995","journal-title":"Am J Cardiol"},{"key":"2026080920424209200_EHV317C188","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","article-title":"Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach","volume":"62","author":"Mukerjee","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"2026080920424209200_EHV317C189","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/eurheartj\/ehq170","article-title":"Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension","volume":"31","author":"Montani","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080920424209200_EHV317C190","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"N Engl J Med"},{"key":"2026080920424209200_EHV317C191","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/0003-4819-114-6-464","article-title":"Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease","volume":"114","author":"Stewart","year":"1991","journal-title":"Ann Intern Med"},{"key":"2026080920424209200_EHV317C192","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cardiores.2003.11.026","article-title":"The endothelin system in pulmonary arterial hypertension","volume":"61","author":"Gali\u00e9","year":"2004","journal-title":"Cardiovasc Res"},{"key":"2026080920424209200_EHV317C193","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jacc.2005.04.050","article-title":"Ambrisentan therapy for pulmonary arterial hypertension","volume":"46","author":"Gali\u00e9","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C194","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension. Results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Gali\u00e9","year":"2008","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C195","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1378\/chest.08-1028","article-title":"Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities","volume":"135","author":"McGoon","year":"2009","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C196","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"2026080920424209200_EHV317C197","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"2026080920424209200_EHV317C198","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1183\/09031936.04.00028404","article-title":"Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2","volume":"24","author":"Humbert","year":"2004","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C199","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","article-title":"Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial","volume":"371","author":"Gali\u00e8","year":"2008","journal-title":"Lancet"},{"key":"2026080920424209200_EHV317C200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Gali\u00e8","year":"2006","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C201","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N Engl J Med"},{"key":"2026080920424209200_EHV317C202","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1164\/rccm.200411-1587OC","article-title":"Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells","volume":"172","author":"Wharton","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C203","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00395-004-0504-5","article-title":"Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells","volume":"100","author":"Tantini","year":"2005","journal-title":"Basic Res Cardiol"},{"key":"2026080920424209200_EHV317C204","first-page":"1488","article-title":"Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study","volume":"44","author":"Ghofrani","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C205","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Gali\u00e8","year":"2005","journal-title":"N Engl J Med"},{"key":"2026080920424209200_EHV317C206","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2003.10.056","article-title":"Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study","volume":"43","author":"Sastry","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C207","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/eurheartj\/ehq011","article-title":"Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial","volume":"31","author":"Iversen","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080920424209200_EHV317C208","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ahj.2005.09.006","article-title":"A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension","volume":"151","author":"Singh","year":"2006","journal-title":"Am Heart J"},{"key":"2026080920424209200_EHV317C209","doi-asserted-by":"crossref","first-page":"521","DOI":"10.7326\/0003-4819-149-8-200810210-00004","article-title":"Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension","volume":"149","author":"Simonneau","year":"2008","journal-title":"Ann Intern Med"},{"key":"2026080920424209200_EHV317C210","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2125.2010.03831.x","article-title":"Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension","volume":"71","author":"Vachiery","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"2026080920424209200_EHV317C211","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Gali\u00e8","year":"2009","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C212","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1164\/rccm.201101-0093OC","article-title":"Vardenafil in pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled study","volume":"183","author":"Jing","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C213","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM199507273330403","article-title":"Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension","volume":"333","author":"Giaid","year":"1995","journal-title":"N Engl J Med"},{"key":"2026080920424209200_EHV317C214","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"key":"2026080920424209200_EHV317C215","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1183\/09031936.00105914","article-title":"PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in PAH","volume":"45","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C216","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0026-895X(25)10547-6","article-title":"Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades","volume":"48","author":"Jones","year":"1995","journal-title":"Mol Pharmacol"},{"key":"2026080920424209200_EHV317C217","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF03256644","article-title":"Prostanoids for pulmonary arterial hypertension","volume":"2","author":"Gali\u00e8","year":"2003","journal-title":"Am J Respir Med"},{"key":"2026080920424209200_EHV317C218","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0735-1097(02)01786-2","article-title":"Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomised, double-blind placebo-controlled trial","volume":"39","author":"Gali\u00e8","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C219","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0735-1097(03)00463-7","article-title":"Beraprost therapy for pulmonary arterial hypertension","volume":"41","author":"Barst","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C220","first-page":"485","article-title":"Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol)","volume":"112","author":"Rubin","year":"1990","journal-title":"Results of a randomized trial. Ann Intern Med"},{"key":"2026080920424209200_EHV317C221","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [see comments]","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"2026080920424209200_EHV317C222","first-page":"425","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease","volume":"132","author":"Badesch","year":"2000","journal-title":"A randomized, controlled trial [see comments]. Ann Intern Med"},{"key":"2026080920424209200_EHV317C223","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/01.CIR.99.14.1858","article-title":"Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects","volume":"99","author":"Rosenzweig","year":"1999","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C224","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hep.510300307","article-title":"Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): a study of 15 patients with moderate to severe portopulmonary hypertension","volume":"30","author":"Krowka","year":"1999","journal-title":"Hepatology"},{"key":"2026080920424209200_EHV317C225","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1164\/rccm.200204-330OC","article-title":"Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension","volume":"167","author":"Nunes","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C226","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.healun.2006.12.014","article-title":"Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension","volume":"26","author":"Cabrol","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"2026080920424209200_EHV317C227","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1742-1241.2008.01811.x","article-title":"Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension","volume":"160","author":"Doran","year":"2008","journal-title":"Int J Clin Pract Suppl"},{"key":"2026080920424209200_EHV317C228","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ahj.2013.08.007","article-title":"EPITOME-2: an open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension","volume":"167","author":"Sitbon","year":"2014","journal-title":"Am Heart J"},{"key":"2026080920424209200_EHV317C229","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost in severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N Engl J Med"},{"key":"2026080920424209200_EHV317C230","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1164\/rccm.200603-358OC","article-title":"Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension","volume":"174","author":"McLaughlin","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C231","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1183\/09031936.06.00057906","article-title":"Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension","volume":"4","author":"Hoeper","year":"2006","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C232","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/hrt.80.2.151","article-title":"Long-term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension","volume":"80","author":"Higenbottam","year":"1998","journal-title":"Heart"},{"key":"2026080920424209200_EHV317C233","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension","volume":"165","author":"Simonneau","year":"2002","journal-title":"A double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C234","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.healun.2009.09.005","article-title":"Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial","volume":"29","author":"Hiremath","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"2026080920424209200_EHV317C235","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1378\/chest.129.3.683","article-title":"Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial","volume":"129","author":"Tapson","year":"2006","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C236","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FJC.0b013e31802b3184","article-title":"Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension","volume":"49","author":"Sitbon","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026080920424209200_EHV317C237","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2010.01.027","article-title":"Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial","volume":"55","author":"McLaughlin","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C238","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1378\/chest.11-2212","article-title":"Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and\/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial","volume":"142","author":"Tapson","year":"2012","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C239","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1378\/chest.12-2875","article-title":"Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and\/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial","volume":"144","author":"Tapson","year":"2013","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C240","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.112.124388","article-title":"Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial","volume":"127","author":"Jing","year":"2013","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C241","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1183\/09031936.00137511","article-title":"Selexipag, an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension","volume":"40","author":"Simonneau","year":"2012","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C242","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jacc.2013.05.075","article-title":"Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension)","volume":"62","author":"Chen","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C243","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jacc.2013.06.032","article-title":"New treatment strategies for pulmonary arterial hypertension: hopes or hypes","volume":"62","author":"Gali\u00e8","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C244","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1093\/eurheartj\/ehq152","article-title":"Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses","volume":"31","author":"Gali\u00e8","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080920424209200_EHV317C245","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.healun.2011.11.002","article-title":"Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: an observational study","volume":"31","author":"Kemp","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"2026080920424209200_EHV317C246","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1183\/09031936.00116313","article-title":"Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study","volume":"43","author":"Sitbon","year":"2014","journal-title":"Eur Respir J"},{"issue":"9","key":"2026080920424209200_EHV317C247","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension","volume":"379","author":"Gali\u00e8","year":"2015","journal-title":"New Engl J Med"},{"key":"2026080920424209200_EHV317C248","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(15)61538-8","article-title":"Effect of selexipag on morbidity\/mortality in pulmonary arterial hypertension: results of the GRIPHON study","author":"McLaughlin","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C249","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1755-5922.2011.00279.x","article-title":"ARIES-3: ambrisentan therapy in a diverse population of patients with pulmonary hypertension","volume":"30","author":"Badesch","year":"2012","journal-title":"Cardiovasc Ther"},{"key":"2026080920424209200_EHV317C250","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/eurheartj\/ehi728","article-title":"Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension","volume":"27","author":"Provencher","year":"2006","journal-title":"Eur Heart J"},{"key":"2026080920424209200_EHV317C251","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1183\/13993003.02044-2014","article-title":"Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension","volume":"46","author":"McLaughlin","year":"2015","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C252","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1183\/09031936.00209914","article-title":"Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: real-world insights","volume":"46","author":"Dardi","year":"2015","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C253","first-page":"297","article-title":"Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension","volume":"32","author":"Sandoval","year":"1998","journal-title":"A therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C254","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1378\/chest.06-1227","article-title":"Atrial septostomy in treatment of end-stage right heart failure in Patients with pulmonary hypertension","volume":"131","author":"Kurzyna","year":"2007","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C255","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1378\/chest.07-1222","article-title":"Long-term follow-up of a fenestrated Amplatzer atrial septal occluder in pulmonary arterial hypertension","volume":"133","author":"Althoff","year":"2008","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C256","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2009.04.016","article-title":"Interventional and surgical modalities of treatment in pulmonary arterial hypertension","author":"Keogh","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C257","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1183\/09031936.00070209","article-title":"Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension","volume":"35","author":"Sztrymf","year":"2010","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C258","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1097\/01.CCM.0000280433.74246.9E","article-title":"Management strategies for patients with pulmonary hypertension in the intensive care unit","volume":"35","author":"Zamanian","year":"2007","journal-title":"Crit Care Med"},{"key":"2026080920424209200_EHV317C259","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1186\/cc9264","article-title":"Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review","volume":"14","author":"Price","year":"2010","journal-title":"Crit Care"},{"key":"2026080920424209200_EHV317C260","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1164\/rccm.201104-0662CI","article-title":"Intensive care unit management of patients with severe pulmonary hypertension and right heart failure","volume":"184","author":"Hoeper","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C261","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/MAT.0000000000000021","article-title":"Extracorporeal membrane oxygenation as a novel bridging strategy for acute right heart failure in group 1 pulmonary arterial hypertension","volume":"60","author":"Rosenzweig","year":"2014","journal-title":"ASAIO J"},{"key":"2026080920424209200_EHV317C262","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1111\/j.1600-6143.2010.03192.x","article-title":"Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation","volume":"10","author":"Olsson","year":"2010","journal-title":"Am J Transplant"},{"key":"2026080920424209200_EHV317C263","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1164\/rccm.201109-1599OC","article-title":"Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation","volume":"185","author":"Fuehner","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C264","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.healun.2011.03.002","article-title":"Impact of extracorporeal life support on outcome in patients with idiopathic pulmonary arterial hypertension awaiting lung transplantation","volume":"30","author":"de Perrot","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"2026080920424209200_EHV317C265","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1600-6143.2009.02549.x","article-title":"Bridge to thoracic organ transplantation in patients with pulmonary arterial hypertension using a pumpless lung assist device","volume":"9","author":"Strueber","year":"2009","journal-title":"Am J Transplant"},{"key":"2026080920424209200_EHV317C266","first-page":"880","article-title":"Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart lung transplantation report\u20142006","volume-title":"J Heart Lung Transplant","author":"Trulock","year":"2006"},{"key":"2026080920424209200_EHV317C267","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.athoracsur.2008.05.049","article-title":"Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension","volume":"86","author":"Toyoda","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"2026080920424209200_EHV317C268","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejcts.2010.02.039","article-title":"Long-term outcome of double-lung and heart\u2212lung transplantation for pulmonary hypertension: a comparative retrospective study of 219 patients","volume":"38","author":"Fadel","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026080920424209200_EHV317C269","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jtcvs.2011.08.055","article-title":"Outcome of patients with pulmonary arterial hypertension referred for lung transplantation: a 14-year single-center experience","volume":"143","author":"de Perrot","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026080920424209200_EHV317C270","first-page":"1073","article-title":"The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report\u20142012","volume-title":"J Heart Lung Transplant","author":"Christie"},{"key":"2026080920424209200_EHV317C271","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1053-2498(01)00420-X","article-title":"Heart-lung or lung transplantation for Eisenmenger syndrome","volume":"21","author":"Waddell","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"2026080920424209200_EHV317C272","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jtcvs.2004.07.058","article-title":"Repair of congenital heart lesions combined with lung transplantation for the treatment of severe pulmonary hypertension: a 13-year experience","volume":"129","author":"Choong","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026080920424209200_EHV317C273","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1002\/sim.5403","article-title":"Biomarkers and surrogate endpoints in clinical trials","volume":"31","author":"Fleming","year":"2012","journal-title":"Statistic Med"},{"key":"2026080920424209200_EHV317C274","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1377\/hlthaff.24.1.67","article-title":"Surrogate endpoints and FDA accelerated approval process","volume":"24","author":"Fleming","year":"2005","journal-title":"Health Affairs"},{"key":"2026080920424209200_EHV317C275","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ahj.2006.09.008","article-title":"Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension","volume":"153","author":"Tongers","year":"2007","journal-title":"Am Heart J"},{"key":"2026080920424209200_EHV317C276","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1164\/ajrccm.165.3.200109-0130c","article-title":"Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension","volume":"165","author":"Hoeper","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C277","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijcard.2011.02.059","article-title":"Right atrial flutter isthmus ablation is feasible and results in acute clinical improvement in patients with persistent atrial flutter and severe pulmonary arterial hypertension","volume":"149","author":"Showkathali","year":"2011","journal-title":"Int J Cardiol"},{"key":"2026080920424209200_EHV317C278","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1378\/chest.10-1134","article-title":"Recurrent hemoptysis: an emerging life-threatening complication in idiopathic pulmonary arterial hypertension","volume":"139","author":"Zylkowska","year":"2011","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C279","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1378\/chest.11-2794","article-title":"Pulmonary artery dilatation correlates with the risk of unexpected death in chronic arterial or thromboembolic pulmonary hypertension","volume":"142","author":"Zylkowska","year":"2012","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C280","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/heartjnl-2011-301132","article-title":"Extensive right pulmonary artery dissection in a young patient with chronic pulmonary hypertension","volume":"98","author":"Russo","year":"2012","journal-title":"Heart"},{"key":"2026080920424209200_EHV317C281","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.4187\/respcare.02252","article-title":"Complications leading to sudden cardiac death in pulmonary arterial hypertension","volume":"58","author":"Demerouti","year":"2013","journal-title":"Respiratory Care"},{"key":"2026080920424209200_EHV317C282","first-page":"543","article-title":"Left main coronary artery compression from pulmonary artery enlargement due to pulmonary hypertension: a contemporary review and argument for percutaneous revascularization","volume":"76","author":"Lee","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"2026080920424209200_EHV317C283","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1183\/09031936.00056110","article-title":"Pulmonary arterial hypertension: a comparison between children and adults","volume":"37","author":"Barst","year":"2011","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C284","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCULATIONAHA.111.026591","article-title":"Survival in childhood pulmonary arterial hypertension","volume":"125","author":"Barst","year":"2012","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C285","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/CIRCULATIONAHA.110.969584","article-title":"Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005","volume":"124","author":"van Loon","year":"2011","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C286","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1136\/hrt.2009.182378","article-title":"Childhood idiopathic pulmonary arterial hypertension: a national cohort study","volume":"96","author":"Moledina","year":"2010","journal-title":"Heart"},{"key":"2026080920424209200_EHV317C287","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(11)61621-8","article-title":"Clinical features of paediatric pulmonary hypertension: a registry study","volume":"379","author":"Berger","year":"2012","journal-title":"Lancet"},{"key":"2026080920424209200_EHV317C288","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1183\/09031936.00065713","article-title":"Registries for paediatric pulmonary hypertension","volume":"42","author":"Hansmann","year":"2013","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C289","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4103\/2045-8932.83456","article-title":"A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: report from the PVRI Pediatric Taskforce, Panama 2011","volume":"1","author":"Cerro","year":"2011","journal-title":"Pulm Circ"},{"key":"2026080920424209200_EHV317C290","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1183\/09031936.00140112","article-title":"Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice","volume":"42","author":"Beghetti","year":"2013","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C291","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1183\/09059180.00008510","article-title":"Issues related to the management and therapy of paediatric pulmonary hypertension","volume":"19","author":"Schulze-Neick","year":"2010","journal-title":"Eur Respir Rev"},{"key":"2026080920424209200_EHV317C292","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4103\/2045-8932.109931","article-title":"Clinical trials in neonates and children: report of the Pulmonary Hypertension Academic Research Consortium Pediatric Advisory Committee","volume":"3","author":"Adatia","year":"2013","journal-title":"Pulm Circ"},{"key":"2026080920424209200_EHV317C293","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/hrt.2006.096412","article-title":"Epoprostenol treatment in children with severe pulmonary hypertension","volume":"93","author":"Lammers","year":"2007","journal-title":"Heart"},{"key":"2026080920424209200_EHV317C294","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/01.CIR.99.9.1197","article-title":"Vasodilator therapy for primary pulmonary hypertension in children","volume":"99","author":"Barst","year":"1999","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C295","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jpeds.2010.09.025","article-title":"Add-on therapy with subcutaneous treprostinil for refractory pediatric pulmonary hypertension","volume":"158","author":"Levy","year":"2011","journal-title":"J Pediatr"},{"key":"2026080920424209200_EHV317C296","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2007.09.031","article-title":"Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension","volume":"51","author":"Ivy","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C297","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0009-9236(03)00005-5","article-title":"Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension","volume":"73","author":"Barst","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"2026080920424209200_EHV317C298","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2005.01.066","article-title":"Effects of long-term bosentan in children with pulmonary arterial hypertension","volume":"46","author":"Rosenzweig","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C299","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1365-2125.2009.03532.x","article-title":"Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study","volume":"68","author":"Beghetti","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"2026080920424209200_EHV317C300","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCULATIONAHA.110.016667","article-title":"A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension","volume":"125","author":"Barst","year":"2012","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C301","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1161\/CIRCULATIONAHA.113.005698","article-title":"STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension","volume":"129","author":"Barst","year":"2014","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C302","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00246-012-0180-4","article-title":"Initial experience with tadalafil in pediatric pulmonary arterial hypertension","volume":"33","author":"Takatsuki","year":"2012","journal-title":"Pediatr Cardiol"},{"key":"2026080920424209200_EHV317C303","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/heartjnl-2013-304895","article-title":"Sildenafil add-on therapy in paediatric pulmonary arterial hypertension, experiences of a national referral centre","volume":"100","author":"Douwes","year":"2014","journal-title":"Heart"},{"key":"2026080920424209200_EHV317C304","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/hrt.2005.077669","article-title":"Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension","volume":"92","author":"Micheletti","year":"2006","journal-title":"Heart"},{"key":"2026080920424209200_EHV317C305","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIRCINTERVENTIONS.112.000091","article-title":"Patent ductus arteriosus stenting (transcatheter Potts shunt) for palliation of suprasystemic pulmonary arterial hypertension: a case series","volume":"6","author":"Boudjemline","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"2026080920424209200_EHV317C306","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1093\/ejcts\/ezu445","article-title":"Palliative Potts shunt for the treatment of children with drug-refractory pulmonary arterial hypertension: updated data from the first 24 patients","volume":"47","author":"Baruteau","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026080920424209200_EHV317C307","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.healun.2013.01.1049","article-title":"Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: initial clinical experience","volume":"32","author":"Esch","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"2026080920424209200_EHV317C308","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1183\/09031936.00030414","article-title":"Identification of treatment goals in paediatric pulmonary arterial hypertension","volume":"44","author":"Ploegstra","year":"2014","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C309","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2165\/00003495-200868080-00004","article-title":"Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome","volume":"68","author":"Gali\u00e8","year":"2008","journal-title":"Drugs"},{"key":"2026080920424209200_EHV317C310","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/hrt.2006.098848","article-title":"Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease","volume":"93","author":"Engelfriet","year":"2007","journal-title":"Heart"},{"key":"2026080920424209200_EHV317C311","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jacc.2008.11.025","article-title":"Eisenmenger syndrome: a clinical perspective in a new therapeutic era of pulmonary arterial hypertension","volume":"53","author":"Beghetti","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C312","first-page":"1845","article-title":"Eisenmenger syndrome","volume":"19","author":"Daliento","year":"1998","journal-title":"Factors relating to deterioration and death. Eur Heart J"},{"key":"2026080920424209200_EHV317C313","first-page":"100","article-title":"Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome","volume":"15","author":"Hopkins","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"2026080920424209200_EHV317C314","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurheartj\/eht072","article-title":"Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups","volume":"35","author":"Manes","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080920424209200_EHV317C315","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00019501-200502000-00004","article-title":"The remarkable right ventricle of patients with Eisenmenger syndrome","volume":"16","author":"Hopkins","year":"2005","journal-title":"Coron Artery Dis"},{"key":"2026080920424209200_EHV317C316","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/CIRCULATIONAHA.105.592386","article-title":"Pulmonary vascular disease in adults with congenital heart disease","volume":"115","author":"Diller","year":"2007","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C317","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/0002-9149(91)90284-R","article-title":"Late results (30 to 35 years) after operative closure of isolated ventricular septal defect from 1954 to 1960","volume":"68","author":"Moller","year":"1991","journal-title":"Am J Cardiol"},{"key":"2026080920424209200_EHV317C318","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1017\/S1047951107001849","article-title":"Pulmonary arterial hypertension in congenital cardiac disease\u2014the need for refinement of the Evian-Venice classification","volume":"18","author":"van Albada","year":"2008","journal-title":"Cardiol Young"},{"key":"2026080920424209200_EHV317C319","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1017\/S1047951107001850","article-title":"Classifying pulmonary hypertension in the setting of the congenitally malformed heart\u2014cleaning up a dog's dinner","volume":"18","author":"Schulze-Neick","year":"2008","journal-title":"Cardiol Young"},{"key":"2026080920424209200_EHV317C320","article-title":"Measurement, interpretation and use of hemodynamic parameters","author":"Lopes","year":"2009","journal-title":"Cardiol Young"},{"key":"2026080920424209200_EHV317C321","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jacc.2007.04.056","article-title":"Pulmonary arterial thrombosis in Eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity","volume":"50","author":"Broberg","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C322","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2007.04.078","article-title":"Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study","volume":"127","author":"Gatzoulis","year":"2007","journal-title":"Int J Cardiol"},{"key":"2026080920424209200_EHV317C323","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.amjcard.2010.12.051","article-title":"Ambrisentan for pulmonary arterial hypertension due to congenital heart disease","volume":"107","author":"Zuckerman","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C324","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.105.603001","article-title":"Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study","volume":"114","author":"Mukhopadhyay","year":"2006","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C325","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1002\/art.38172","article-title":"Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension","volume":"65","author":"Khanna","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2026080920424209200_EHV317C326","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1016\/j.lpm.2014.06.007","article-title":"Update in systemic sclerosis-associated pulmonary arterial hypertension","volume":"43","author":"Gashouta","year":"2014","journal-title":"Presse Med"},{"key":"2026080920424209200_EHV317C327","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2026080920424209200_EHV317C328","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/art.30541","article-title":"Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival","volume":"63","author":"Humbert","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2026080920424209200_EHV317C329","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1183\/09031936.00182813","article-title":"Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients","volume":"44","author":"Hao","year":"2014","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C330","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/rheumatology\/ken488","article-title":"Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinerAIR-Sclerodermie study","volume":"48","author":"Hachulla","year":"2009","journal-title":"Rheumatology"},{"key":"2026080920424209200_EHV317C331","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3899\/jrheum.100245","article-title":"Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies","volume":"37","author":"Avouac","year":"2010","journal-title":"J Rheumatol"},{"key":"2026080920424209200_EHV317C332","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1002\/art.34501","article-title":"Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension","volume":"64","author":"Gunther","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2026080920424209200_EHV317C333","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1183\/09031936.00025413","article-title":"Does left heart disease cause most systemic sclerosis associated pulmonary hypertension","volume":"42","author":"Coghlan","year":"2013","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C334","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1183\/09031936.00057010","article-title":"Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension","volume":"36","author":"Humbert","year":"2010","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C335","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/art.22069","article-title":"Clinical differences between idiopathic and scleroderma-related pulmonary hypertension","volume":"54","author":"Fisher","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2026080920424209200_EHV317C336","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1136\/annrheumdis-2012-202489","article-title":"Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era","volume":"72","author":"Launay","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2026080920424209200_EHV317C337","first-page":"e65","article-title":"Pulmonary veno-occlusive disease: the bete noire of pulmonary hypertension in connective tissue diseases","volume":"40","author":"O'Callaghan","year":"2011","journal-title":"Presse Med"},{"key":"2026080920424209200_EHV317C338","first-page":"H348","article-title":"Pulmonary injury and prostaglandin production during endotoxemia in conscious sheep","volume":"240","author":"Demling","year":"1981","journal-title":"Am J Physiol"},{"key":"2026080920424209200_EHV317C339","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.23303","article-title":"Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases","volume":"58","author":"Ja\u00efs","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2026080920424209200_EHV317C340","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/ard.2007.077149","article-title":"Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials","volume":"67","author":"Avouac","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2026080920424209200_EHV317C341","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1016\/j.lpm.2014.01.020","article-title":"Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary working group","volume":"43","author":"Launay","year":"2014","journal-title":"Presse Med"},{"key":"2026080920424209200_EHV317C342","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(04)16107-2","article-title":"Portopulmonary hypertension and hepatopulmonary syndrome","volume":"363","author":"Hoeper","year":"2004","journal-title":"Lancet"},{"key":"2026080920424209200_EHV317C343","first-page":"561870","article-title":"Transition from hepatopulmonary syndrome to portopulmonary hypertension: a case series of 3 patients","volume":"2013","author":"Zopey","year":"2013","journal-title":"Case Rep Pulmonol"},{"key":"2026080920424209200_EHV317C344","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/hep.21431","article-title":"Portopulmonary hypertension: results from a 10-year screening algorithm","volume":"44","author":"Krowka","year":"2006","journal-title":"Hepatology"},{"key":"2026080920424209200_EHV317C345","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.22275","article-title":"Clinical risk factors for portopulmonary hypertension","volume":"48","author":"Kawut","year":"2008","journal-title":"Hepatology"},{"key":"2026080920424209200_EHV317C346","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1164\/rccm.200809-1472OC","article-title":"Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease","volume":"179","author":"Roberts","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C347","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1378\/chest.11-0160","article-title":"Portopulmonary hypertension: a report from the US-based REVEAL Registry","volume":"141","author":"Krowka","year":"2012","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C348","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/rccm.200804-613OC","article-title":"Portopulmonary hypertension: survival and prognostic factors","volume":"178","author":"Le Pavec","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C349","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2005.10.013","article-title":"Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension","volume":"130","author":"Provencher","year":"2006","journal-title":"Gastroenterology"},{"key":"2026080920424209200_EHV317C350","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1183\/09031936.00032407","article-title":"Experience with inhaled iloprost and bosentan in portopulmonary hypertension","volume":"30","author":"Hoeper","year":"2007","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C351","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1055\/s-0031-1273393","article-title":"Ambrisentan improves exercise capacity and symptoms in patients with portopulmonary hypertension","volume":"49","author":"Halank","year":"2011","journal-title":"Z Gastroenterol"},{"key":"2026080920424209200_EHV317C352","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1183\/09031936.06.00030206","article-title":"Sildenafil treatment for portopulmonary hypertension","volume":"28","author":"Reichenberger","year":"2006","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C353","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00007890-199702270-00020","article-title":"Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension","volume":"63","author":"Kuo","year":"1997","journal-title":"Transplantation"},{"key":"2026080920424209200_EHV317C354","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1600-6143.2008.02384.x","article-title":"Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups","volume":"8","author":"Swanson","year":"2008","journal-title":"Am J Transplant"},{"key":"2026080920424209200_EHV317C355","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1432-2277.2008.00830.x","article-title":"Initial experience using continuous intravenous treprostinil to manage pulmonary arterial hypertension in patients with end-stage liver disease","volume":"22","author":"Sakai","year":"2009","journal-title":"Transpl Int"},{"key":"2026080920424209200_EHV317C356","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1183\/09031936.00117511","article-title":"Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension","volume":"41","author":"Savale","year":"2013","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C357","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1183\/09031936.00138706","article-title":"Results of European post-marketing surveillance of bosentan in pulmonary hypertension","volume":"30","author":"Humbert","year":"2007","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C358","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1111\/ajt.12385","article-title":"Role of pretransplant echocardiographic evaluation in predicting outcomes following liver transplantation","volume":"13","author":"Kia","year":"2013","journal-title":"Am J Transplant"},{"key":"2026080920424209200_EHV317C359","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/jlts.2000.6356","article-title":"Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation","volume":"6","author":"Krowka","year":"2000","journal-title":"Liver Transplant"},{"key":"2026080920424209200_EHV317C360","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1600-6143.2006.01701.x","article-title":"The impact of treatment of portopulmonary hypertension on survival following liver transplantation","volume":"7","author":"Ashfaq","year":"2007","journal-title":"Am J Transplant"},{"key":"2026080920424209200_EHV317C361","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MEG.0b013e32835c504b","article-title":"Oral vasodilator therapy in patients with moderate to severe portopulmonary hypertension as a bridge to liver transplantation","volume":"25","author":"Raevens","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2026080920424209200_EHV317C362","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00007890-199802270-00001","article-title":"Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension","volume":"65","author":"Plotkin","year":"1998","journal-title":"Transplantation"},{"key":"2026080920424209200_EHV317C363","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/lt.21310","article-title":"Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension","volume":"14","author":"Austin","year":"2008","journal-title":"Liver Transplant"},{"key":"2026080920424209200_EHV317C364","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/TP.0b013e3181636f3f","article-title":"Indications for and outcomes after combined lung and liver transplantation: a single-center experience on 13 consecutive cases","volume":"85","author":"Grannas","year":"2008","journal-title":"Transplantation"},{"key":"2026080920424209200_EHV317C365","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0735-1097(10)80121-4","article-title":"Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations","volume":"17","author":"Robalino","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C366","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1136\/hrt.2005.076794","article-title":"Highly active antiretroviral therapy compared with HAART and bosentan in combination in patients with HIV-associated pulmonary hypertension","volume":"92","author":"Barbaro","year":"2006","journal-title":"Heart"},{"key":"2026080920424209200_EHV317C367","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/QAD.0b013e328331c65e","article-title":"HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era","volume":"24","author":"Degano","year":"2010","journal-title":"AIDS"},{"key":"2026080920424209200_EHV317C368","first-page":"990","article-title":"HIV-associated primary pulmonary hypertension","volume":"155","author":"Opravil","year":"1997","journal-title":"A case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C369","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1164\/rccm.200704-541OC","article-title":"Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era","volume":"177","author":"Sitbon","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C370","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1164\/rccm.200404-445OC","article-title":"Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension","volume":"170","author":"Sitbon","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C371","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MD.0b013e31818193bb","article-title":"Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology","volume":"87","author":"Montani","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"2026080920424209200_EHV317C372","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/01.pas.0000209834.69972.e5","article-title":"Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases","volume":"30","author":"Lantuejoul","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"2026080920424209200_EHV317C373","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1164\/ajrccm.157.5.9708065","article-title":"Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis","volume":"157","author":"Humbert","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C374","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1164\/ajrccm.162.5.9912045","article-title":"Pulmonary veno-occlusive disease","volume":"162","author":"Mandel","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C375","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-109-2-106","article-title":"Familial pulmonary capillary hemangiomatosis resulting in primary pulmonary hypertension","volume":"109","author":"Langleben","year":"1988","journal-title":"Ann Intern Med"},{"key":"2026080920424209200_EHV317C376","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1378\/chest.13-2366","article-title":"EIF2AK4 mutations in pulmonary capillary hemangiomatosis","volume":"145","author":"Best","year":"2014","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C377","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1183\/09031936.00097911","article-title":"Ventilation\/perfusion lung scan in pulmonary veno-occlusive disease","volume":"40","author":"Seferian","year":"2012","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C378","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1183\/09031936.06.00054105","article-title":"Occult alveolar haemorrhage in pulmonary veno-occlusive disease","volume":"27","author":"Rabiller","year":"2006","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C379","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1183\/09031936.00017809","article-title":"Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease","volume":"34","author":"Montani","year":"2009","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C380","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.healun.2012.06.002","article-title":"World Health Organization Pulmonary Hypertension Group 2: pulmonary hypertension due to left heart disease in the adult\u2014a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation","volume":"31","author":"Fang","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"2026080920424209200_EHV317C381","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(00)01102-5","article-title":"Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure","volume":"37","author":"Ghio","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C382","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCHEARTFAILURE.110.958801","article-title":"Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction","volume":"4","author":"Thenappan","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026080920424209200_EHV317C383","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1378\/chest.08-2008","article-title":"Association of the metabolic syndrome with pulmonary venous hypertension","volume":"136","author":"Robbins","year":"2009","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C384","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jacc.2011.06.076","article-title":"Pulmonary pressures and death in heart failure: a community study","volume":"59","author":"Bursi","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C385","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1378\/chest.12-1653","article-title":"Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in \u201cout-of-proportion\u201d pulmonary hypertension","volume":"143","author":"Gerges","year":"2013","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C386","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.102.14.1718","article-title":"Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management","volume":"102","author":"Moraes","year":"2000","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C387","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0002-9149(01)01864-1","article-title":"Relation of pulmonary arterial diastolic and mean pulmonary arterial wedge pressures in patients with and without pulmonary hypertension","volume":"88","author":"Rapp","year":"2001","journal-title":"Am J Cardiol"},{"key":"2026080920424209200_EHV317C388","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jchf.2013.05.001","article-title":"Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure","volume":"1","author":"Miller","year":"2013","journal-title":"JACC Heart Fail"},{"key":"2026080920424209200_EHV317C389","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jchf.2014.07.010","article-title":"The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease","volume":"3","author":"Tampakakis","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2026080920424209200_EHV317C390","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1378\/chest.13-1510","article-title":"Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure","volume":"145","author":"Pellegrini","year":"2014","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C391","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jchf.2014.09.002","article-title":"Characterization of pulmonary hypertension in heart failure using the diastolic pressure gradient: limitations of a solitary measurement","volume":"3","author":"Chatterjee","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2026080920424209200_EHV317C392","first-page":"1787","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology","volume":"33","author":"McMurray","year":"2012","journal-title":"Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J"},{"key":"2026080920424209200_EHV317C393","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ahj.2009.02.022","article-title":"Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database","volume":"157","author":"Khush","year":"2009","journal-title":"Am Heart J"},{"key":"2026080920424209200_EHV317C394","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.athoracsur.2008.05.016","article-title":"Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices","volume":"86","author":"Patel","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"2026080920424209200_EHV317C395","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.healun.2009.05.030","article-title":"Reversal of secondary pulmonary hypertension by axial and pulsatile mechanical circulatory support","volume":"29","author":"Torre-Amione","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"2026080920424209200_EHV317C396","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.hfc.2012.04.009","article-title":"Pulmonary hypertension associated with left-sided heart disease","volume":"8","author":"Barnett","year":"2012","journal-title":"Heart Fail Clin"},{"key":"2026080920424209200_EHV317C397","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.113.001458","article-title":"Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study","volume":"128","author":"Bonderman","year":"2013","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C398","first-page":"1193","article-title":"Prognostic factors in COPD patients receiving long-term oxygen therapy","volume":"107","author":"Oswald-Mammosser","year":"1995","journal-title":"Importance of pulmonary artery pressure. Chest"},{"key":"2026080920424209200_EHV317C399","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1164\/ajrccm.164.2.2006129","article-title":"\u201cNatural history\u201d of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease","volume":"164","author":"Kessler","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C400","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1378\/chest.129.3.746","article-title":"Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis","volume":"129","author":"Lettieri","year":"2006","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C401","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1378\/chest.127.5.1531","article-title":"Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation","volume":"127","author":"Thabut","year":"2005","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C402","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1164\/rccm.200401-006OC","article-title":"Severe pulmonary hypertension and chronic obstructive pulmonary disease","volume":"172","author":"Chaouat","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C403","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1164\/rccm.200210-1130OC","article-title":"Echocardiographic assessment of pulmonary hypertension in patients with advance lung disease","volume":"167","author":"Arcasoy","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C404","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1164\/rccm.200811-1691OC","article-title":"Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension","volume":"179","author":"Fisher","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C405","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.rmed.2008.03.022","article-title":"Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis","volume":"102","author":"Nathan","year":"2008","journal-title":"Respir Med"},{"key":"2026080920424209200_EHV317C406","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1378\/chest.97.2.268","article-title":"Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease","volume":"97","author":"Agusti","year":"1990","journal-title":"Chest"},{"key":"2026080920424209200_EHV317C407","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(96)90011-2","article-title":"Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease","volume":"347","author":"Barbera","year":"1996","journal-title":"Lancet"},{"key":"2026080920424209200_EHV317C408","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJM198106253042606","article-title":"Inhibition of hypoxic pulmonary vasoconstriction by nifedipine","volume":"304","author":"Simonneau","year":"1981","journal-title":"N Engl J Med"},{"key":"2026080920424209200_EHV317C409","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1465-9921-6-88","article-title":"Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease","volume":"6","author":"Morrell","year":"2005","journal-title":"Respir Res"},{"key":"2026080920424209200_EHV317C410","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00005344-199803000-00006","article-title":"Long-term effects of cicletanine on secondary pulmonary hypertension","volume":"31","author":"Saadjian","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026080920424209200_EHV317C411","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1183\/09031936.00011308","article-title":"A randomised, controlled trial of bosentan in severe COPD","volume":"32","author":"Stolz","year":"2008","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C412","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1164\/rccm.200907-0988OC","article-title":"Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension","volume":"181","author":"Blanco","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920424209200_EHV317C413","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1002110","article-title":"A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis","volume":"363","author":"Zisman","year":"2010","journal-title":"N Engl J Med"},{"key":"2026080920424209200_EHV317C414","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1183\/09031936.00176312","article-title":"Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial","volume":"42","author":"Blanco","year":"2013","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C415","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/15412555.2011.651180","article-title":"Sildenafil for chronic obstructive pulmonary disease: a randomized crossover trial","volume":"9","author":"Lederer","year":"2012","journal-title":"COPD"},{"key":"2026080920424209200_EHV317C416","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S2213-2600(14)70013-X","article-title":"Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial","volume":"2","author":"Goudie","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2026080920424209200_EHV317C417","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1183\/09031936.00049312","article-title":"Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding","volume":"41","author":"Lang","year":"2013","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C418","first-page":"598","article-title":"Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism","volume":"112","author":"Guerin","year":"2014","journal-title":"Prevalence of CTEPH after pulmonary embolism. Thromb Haemost"},{"key":"2026080920424209200_EHV317C419","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1183\/09031936.00201612","article-title":"Chronic thromboembolic pulmonary hypertension: role of medical therapy","volume":"41","author":"Pepke-Zaba","year":"2013","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C420","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jtcvs.2010.07.010","article-title":"Chronic thromboembolic pulmonary hypertension in pediatric patients","volume":"141","author":"Madani","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026080920424209200_EHV317C421","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1183\/09031936.00181212","article-title":"Chronic thromboembolic pulmonary hypertension: advances from bench to patient management","volume":"41","author":"Pepke-Zaba","year":"2013","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C422","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1160\/TH13-02-0097","article-title":"Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension","volume":"110","author":"Lang","year":"2013","journal-title":"A case-control study. Thromb Haemost"},{"key":"2026080920424209200_EHV317C423","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jcmg.2010.09.013","article-title":"Imaging in pulmonary hypertension","volume":"3","author":"Lang","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080920424209200_EHV317C424","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1161\/CIRCULATIONAHA.105.602565","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"113","author":"Hoeper","year":"2006","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C425","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2214\/ajr.169.1.9207504","article-title":"Mosaic pattern of lung attenuation on CT scans: frequency among patients with pulmonary artery hypertension of different causes","volume":"169","author":"Sherrick","year":"1997","journal-title":"Am J Roentgenol"},{"key":"2026080920424209200_EHV317C426","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00330-011-2290-4","article-title":"Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH)","volume":"22","author":"Ley","year":"2012","journal-title":"Eur Radiol"},{"key":"2026080920424209200_EHV317C427","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11604-014-0319-8","article-title":"Organized thrombus in pulmonary arteries in patients with chronic thromboembolic pulmonary hypertension; imaging with cone beam computed tomography","volume":"32","author":"Sugiyama","year":"2014","journal-title":"Jpn J Radiol"},{"key":"2026080920424209200_EHV317C428","doi-asserted-by":"crossref","first-page":"844","DOI":"10.7326\/0003-4819-103-6-844","article-title":"Fiberoptic angioscopy: role in the diagnosis of chronic pulmonary arterial obstruction","volume":"103","author":"Shure","year":"1985","journal-title":"Ann Intern Med"},{"key":"2026080920424209200_EHV317C429","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/thoraxjnl-2013-203746","article-title":"Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy","volume":"69","author":"Skoro-Sajer","year":"2014","journal-title":"Thorax"},{"key":"2026080920424209200_EHV317C430","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jtcvs.2010.11.024","article-title":"Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry","volume":"141","author":"Mayer","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026080920424209200_EHV317C431","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.athoracsur.2012.04.004","article-title":"Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients","volume":"94","author":"Madani","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"2026080920424209200_EHV317C432","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1183\/09059180.00009211","article-title":"State-of-the-art chronic thromboembolic pulmonary hypertension diagnosis and management","volume":"21","author":"Jenkins","year":"2012","journal-title":"Eur Respir Rev"},{"key":"2026080920424209200_EHV317C433","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(11)61144-6","article-title":"Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial","volume":"378","author":"Vuylsteke","year":"2011","journal-title":"Lancet"},{"key":"2026080920424209200_EHV317C434","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.athoracsur.2006.07.020","article-title":"Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes","volume":"82","author":"Thistlethwaite","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"2026080920424209200_EHV317C435","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.athoracsur.2008.06.037","article-title":"Successful extracorporeal membrane oxygenation support after pulmonary thromboendarterectomy","volume":"86","author":"Berman","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"2026080920424209200_EHV317C436","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.athoracsur.2011.05.035","article-title":"Extracorporeal membrane oxygenation as a bridge to pulmonary endarterectomy","volume":"92","author":"Mydin","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"2026080920424209200_EHV317C437","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1183\/09031936.06.00135905","article-title":"The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study","volume":"28","author":"Hughes","year":"2006","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C438","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1538-7836.2007.02394.x","article-title":"Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension","volume":"5","author":"Skoro-Sajer","year":"2007","journal-title":"Thromb Haemost"},{"key":"2026080920424209200_EHV317C439","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1183\/09031936.00039007","article-title":"Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension","volume":"30","author":"Reichenberger","year":"2007","journal-title":"Eur Respir J"},{"key":"2026080920424209200_EHV317C440","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jacc.2008.08.059","article-title":"Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial","volume":"52","author":"Ja\u00efs","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026080920424209200_EHV317C441","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"key":"2026080920424209200_EHV317C442","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jtcvs.2009.03.053","article-title":"Bosentan as a bridge to pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension","volume":"139","author":"Reesink","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026080920424209200_EHV317C443","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.CIR.103.1.10","article-title":"Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension","volume":"103","author":"Feinstein","year":"2001","journal-title":"Circulation"},{"key":"2026080920424209200_EHV317C444","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/CIRCINTERVENTIONS.112.971390","article-title":"Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension","volume":"5","author":"Kataoka","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"2026080920424209200_EHV317C445","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/CIRCINTERVENTIONS.112.971077","article-title":"Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension","volume":"5","author":"Mizoguchi","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"2026080920424209200_EHV317C446","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1253\/circj.CJ-11-1217","article-title":"Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension","volume":"76","author":"Sugimura","year":"2012","journal-title":"Circ J"},{"key":"2026080920424209200_EHV317C447","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jcin.2013.03.009","article-title":"Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty","volume":"6","author":"Inami","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080920424209200_EHV317C448","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1136\/heartjnl-2012-303549","article-title":"Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension","volume":"99","author":"Andreassen","year":"2013","journal-title":"Heart"},{"key":"2026080920424209200_EHV317C449","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1513\/pats.200605-111LR","article-title":"Current and future management of chronic thromboembolic pulmonary hypertension: from diagnosis to treatment responses","volume":"3","author":"Rubin","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"2026080920424209200_EHV317C450","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/bmj.300.6727.763","article-title":"Pulmonary hypertension due to chronic hypoxia","volume":"300","author":"Peacock","year":"1990","journal-title":"BMJ"},{"issue":"(Suppl 1)","key":"2026080920424209200_EHV317C451","first-page":"I1","article-title":"Recommendations on the management of pulmonary hypertension in clinical practice","volume":"86","year":"2001","journal-title":"Heart"},{"issue":"(Suppl 2)","key":"2026080920424209200_EHV317C452","first-page":"ii1","article-title":"Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland","volume":"63","year":"2008","journal-title":"Thorax"},{"key":"2026080920424209200_EHV317C453","first-page":"170","article-title":"[Standards of care in pulmonary hypertension. Consensus statement of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Spanish Society of Cardiology (SEC)]","volume":"61","author":"Barbera","year":"2008","journal-title":"Rev Esp Cardiol"},{"key":"2026080920424209200_EHV317C454","doi-asserted-by":"crossref","first-page":"e000806","DOI":"10.1136\/bmjopen-2011-000806","article-title":"The trajectory to diagnosis with pulmonary arterial hypertension: a qualitative study","volume":"2","author":"Armstrong","year":"2012","journal-title":"BMJ Open"},{"key":"2026080920424209200_EHV317C455","doi-asserted-by":"crossref","DOI":"10.1016\/S0167-5273(11)70490-9","article-title":"Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011","author":"Ghofrani","year":"2011","journal-title":"Int J Cardiol"},{"key":"2026080920424209200_EHV317C456","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1183\/09059180.00005412","article-title":"Challenges in the diagnosis and treatment of pulmonary arterial hypertension","volume":"21","author":"Vachiery","year":"2012","journal-title":"Eur Respir Rev"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/37\/1\/67\/70579798\/eurheartj_37_1_67.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/37\/1\/67\/70579798\/eurheartj_37_1_67.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:43:43Z","timestamp":1786322623000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/37\/1\/67\/2887599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,29]]},"references-count":456,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,8,29]]},"published-print":{"date-parts":[[2016,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehv317","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,1,1]]},"published":{"date-parts":[[2015,8,29]]}}}